Citation Impact
Citing Papers
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Management of dyspepsia : Report of a working party
1988
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.
1980
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Hyaluronic Acid
1994
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Systemic and topical steroids in inflammatory bowel disease
2004
CD44 is the principal cell surface receptor for hyaluronate
1990 Standout
Functional Gastroduodenal Disorders
2006 Standout
Liver fibrosis
2005 Standout
Sjögren's syndrome
2005 Standout
Ulcerative Colitis
2011 Standout
Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer
1995
Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis
1989
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying
1998
Hydrogels in Regenerative Medicine
2009 Standout
Porphyromonas gingivalis Participates in Pathogenesis of Human Abdominal Aortic Aneurysm by Neutrophil Activation. Proof of Concept in Rats
2011
Dyspepsia and Health Care Seeking in a Community (How Important Are Psychological Factors?)
1998
Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
2015
Update on glucocorticoid action and resistance
2006
Guidelines for the management of inflammatory bowel disease in adults
2011
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Serum YKL-40 is increased in patients with hepatic fibrosis
2000
Reducing Polypharmacy in the Elderly
1990
Autoimmune Conditions Associated With Primary Biliary Cirrhosis: Response to Ursodeoxycholic Acid Therapy
1998
Serum hyaluronan (hyaluronic acid) in breast cancer patients
1990
Ulcerative colitis
2002
The Risk of Stomach Cancer in Patients with Gastric or Duodenal Ulcer Disease
1996
Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery
2013
Retinoid metabolism during development of liver cirrhosis
2005
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
1999 Standout
The NAFLD fibrosis score
2007 Standout
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia
1999
Ulcerative colitis
2012 Standout
Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer
2002
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
2006
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
1987 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Fat-Soluble Vitamin Nutriture in primary Biliary Cirrhosis
1988
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
2016
Medical therapy for ulcerative colitis 2004
2004
Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials
2004
Ulcerative colitis
2016 Standout
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
2000
Definitions of Dyspepsia
1991
Treatment of functional dyspepsia
2005
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease
1988 Standout
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment
2003
Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
1997 Standout
Meta-Analysis of Antisecretory and Gastrokinetic Compounds in Functional Dyspepsia
1998
Levels of circulating tumor necrosis factor α and interleukin‐6 in patients with rheumatoid arthritis. relationship to serum levels of hyaluronan and antigenic keratan sulfate
1993
A sensitive and specific serologic test for detection of Campylobacter pylori infection
1989
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Retinol-Binding Protein: The Serum Transport Protein for Vitamin A*
1989
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Are Frequent Short Gastro-Oesophageal Reflux Episodes the Cause of Symptoms in Patients with Non-Ulcer Dyspepsia Responding to Treatment with Ranitidine?
1995
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
1991 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Evaluation of Liver Fibrosis: A Concise Review
2004
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
1977 Standout
CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS
1965
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Primary Biliary Cirrhosis
1987 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
1993 Standout
Primary Biliary Cirrhosis
2011 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
2002
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies)
1998
Hepatic Stellate Cells and Liver Retinoid Content in Alcoholic Liver Disease in Humans
1998
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
2000
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
The cellular pathology of primary biliary cirrhosis
1985
Continuous self-recording of epigastric pain with two rating scales: Compliance, authenticity, reliability, and sensitivity
1983
Dyspepsia and dyspepsia subgroups: A population-based study
1992
Dyspepsia and dyspepsia subgroups: a population-based study.
1992
The Properties and Turnover of Hyaluronan
2007
Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
1990 StandoutNobel
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Symptom Profiles in Chronic Peptic Ulcer Disease
1985
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
11 Immunology of primary biliary cirrhosis
1987
Tolerogenic Dendritic Cells
2003 StandoutNobel
Placebo-Controlled Trial of Cisapride and Nizatidine in Unselected Patients With Functional Dyspepsia
1998
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
AUTOIMMUNE HEMOLYTIC ANEMIA IN ULCERATIVE COLITIS, CURED BY COLECTOMY
1971
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease
1987
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Sulfasalazine
1983
Works of Anders Nyberg being referenced
The clinical diagnosis of 'gastritis'. Aspects of demographic epidemiology and health care consumption based on a nationwide sample survey.
1984
Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: Increase in activated T and natural killer cells and recruitment of primed memory T cells
1991
Is Duodenal Ulcer Really a Psychosomatic Disease?: A Population-Based Case-Control Study
1987
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis
1996
Impaired release of vitamin a from liver in primary biliary cirrhosis†
1988
The diurnal variation of serum hyaluronan in health and disease
1988
Primary Biliary Cirrhosis: Clinical Features and Outcome, with Special Reference to Asymptomatic Disease
1989
Abdominal Aortic Aneurysm and the Impact of Infectious Burden
2008
Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damage
1988
Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome
1992
Social and economic effects of non-ulcer dyspepsia
1985
The Diagnosis and Therapy Survey October 1978-March 1983, health care consumption and current drug therapy in Sweden with respect to the clinical diagnosis of gastritis
1985
The Clinical Diagnosis of Gastritis
1984
Absence of Therapeutic Benefit from Antacids or Cimetidine in Non-Ulcer Dyspepsia
1986
The “Epigastric Distress Syndrome”
1987
The Clinical Diagnosis of ‘Gastritis’
1984
The Occurrence of Heinz Bodies During Azulfidine Treatment of Ulcerative Colitis
1963
Increased Serum Levels of Hyaluronate in Liver Disease
1985
The clinical diagnosis of gastritis. II. Aspects of current therapy and drug consumption.
1984
RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIAL
1983
Primary Biliary Cirrhosis—Phenotypic Characterization of Immunocompetent Cells in Peripheral Blood and Liver Tissue
1984
Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis.
1986